BMS 186318 is an HIV protease inhibitor. BMS 186318 exhibits better anti- HIV efficacy when used in combination with reverse transcriptase inhibitors such as Stavudine ( HY-B0116 ) and other protease inhibitors such as Saquinavir ( HY-17007 ). BMS 186318 can be used in antiviral research.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > HIV Protease | Products > Signaling Pathways > HIV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.